✦ LIBER ✦

Hormone receptor status influences the locoregional benefit of trastuzumab in patients with nonmetastatic breast cancer

✍ Scribed by Michelle M. Kim; Shaheenah Dawood; Pamela Allen; Aysegul A. Sahin; Wendy A. Woodward; Benjamin D. Smith; Eric A. Strom; Kelly K. Hunt; Funda Meric-Bernstam; Ana Maria Gonzalez-Angulo; Thomas A. Buchholz

Book ID: 112067139
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 774 KB
Volume: 118
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.27502

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hormone Receptor Status Influences the L

Hormone Receptor Status Influences the Locoregional Benefit of Trastuzumab in Patients With Nonmetastatic Breast Cancer

✍ Arsenault, D.; Wright, J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Hormone Receptor Status and TN Stage Inf

Hormone Receptor Status and TN Stage Influence the Locoregional Benefit From Trastuzumab in Patients With HER 2–Positive Breast Cancer After Adjuvant Radiation Therapy

✍ Cao, L.; Cai, G.; Yu, X.; Ma, J.; Yang, Z.; Shao, Z.; Guo, X.; Chen, J. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Hormone receptor status affects locoregi

Hormone receptor status affects locoregional control in HER2-positive breast cancer treated with trastuzumab

✍ Mary Kay Barton 📂 Article 📅 2012 🏛 American Cancer Society 🌐 English ⚖ 140 KB

Hormone Receptor Status Does Not Affect

Hormone Receptor Status Does Not Affect the Clinical Benefit of Trastuzumab Therapy for Patients with Metastatic Breast Cancer

✍ Adam Brufsky; Barry Lembersky; Kathy Schiffman; Grazyna Lieberman; Virginia E. P 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 505 KB

Hormone-receptor expression and activity

Hormone-receptor expression and activity of trastuzumab with chemotherapy in HER2-positive advanced breast cancer patients

✍ Filippo Montemurro; Valentina Rossi; Maria Cossu Rocca; Rossella Martinello; Ele 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB 👁 2 views

The Influence of Receptor Status on Loco

The Influence of Receptor Status on Locoregional Recurrence Risk Among Breast Cancer Patients With Positive Lymph Nodes Following Neoadjuvant Chemotherapy and Mastectomy

✍ Kandula, S.; Switchenko, J.M.; Fasola, C.E.; Mister, D.; Torres, M.A. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 52 KB